These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26301882)

  • 1. Inference for reclassification statistics under nested and non-nested models for biomarker evaluation.
    Shao F; Li J; Fine J; Wong WK; Pencina M
    Biomarkers; 2015; 20(4):240-52. PubMed ID: 26301882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.
    Hilden J; Gerds TA
    Stat Med; 2014 Aug; 33(19):3405-14. PubMed ID: 23553436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicategory reclassification statistics for assessing improvements in diagnostic accuracy.
    Li J; Jiang B; Fine JP
    Biostatistics; 2013 Apr; 14(2):382-94. PubMed ID: 23197381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asymptotic distribution of ∆AUC, NRIs, and IDI based on theory of U-statistics.
    Demler OV; Pencina MJ; Cook NR; D'Agostino RB
    Stat Med; 2017 Sep; 36(21):3334-3360. PubMed ID: 28627112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian reclassification statistics for assessing improvements in diagnostic accuracy.
    Huang Z; Li J; Cheng CY; Cheung C; Wong TY
    Stat Med; 2016 Jul; 35(15):2574-92. PubMed ID: 26875442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying diagnostic accuracy improvement of new biomarkers for competing risk outcomes.
    Wang Z; Cheng Y; Seaberg EC; Becker JT
    Biostatistics; 2020 Feb; 23(2):666-82. PubMed ID: 33324980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of polygenic risk models using multiple performance measures: a critical assessment of discordant results.
    Martens FK; Tonk ECM; Janssens ACJW
    Genet Med; 2019 Feb; 21(2):391-397. PubMed ID: 29895851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measures for evaluation of prognostic improvement under multivariate normality for nested and nonnested models.
    Enserro DM; Demler OV; Pencina MJ; D'Agostino RB
    Stat Med; 2019 Sep; 38(20):3817-3831. PubMed ID: 31211443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The power-integrated discriminant improvement: An accurate measure of the incremental predictive value of additional biomarkers.
    Hayashi K; Eguchi S
    Stat Med; 2019 Jun; 38(14):2589-2604. PubMed ID: 30859601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of reclassification statistics in comparing risk prediction models.
    Cook NR; Paynter NP
    Biom J; 2011 Mar; 53(2):237-58. PubMed ID: 21294152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the effect of multiple genetic risk score models on colorectal cancer risk prediction.
    Xin J; Chu H; Ben S; Ge Y; Shao W; Zhao Y; Wei Y; Ma G; Li S; Gu D; Zhang Z; Du M; Wang M
    Gene; 2018 Oct; 673():174-180. PubMed ID: 29908285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint confidence region estimation for area under ROC curve and Youden index.
    Yin J; Tian L
    Stat Med; 2014 Mar; 33(6):985-1000. PubMed ID: 24123069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Net Reclassification Index and Integrated Discrimination Index Are Not Appropriate for Testing Whether a Biomarker Improves Predictive Performance.
    Burch PM; Glaab WE; Holder DJ; Phillips JA; Sauer JM; Walker EG
    Toxicol Sci; 2017 Mar; 156(1):11-13. PubMed ID: 27815493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A wild bootstrap approach for the selection of biomarkers in early diagnostic trials.
    Zapf A; Brunner E; Konietschke F
    BMC Med Res Methodol; 2015 May; 15():43. PubMed ID: 25925052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.
    Pencina MJ; D'Agostino RB; Demler OV
    Stat Med; 2012 Jan; 31(2):101-13. PubMed ID: 22147389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improvement Screening for Ultra-High Dimensional Data with Censored Survival Outcomes and Varying Coefficients.
    Yue M; Li J
    Int J Biostat; 2017 May; 13(1):. PubMed ID: 28541925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A direct method to evaluate the time-dependent predictive accuracy for biomarkers.
    Shen W; Ning J; Yuan Y
    Biometrics; 2015 Jun; 71(2):439-49. PubMed ID: 25758584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New metrics for assessing diagnostic potential of candidate biomarkers.
    Pickering JW; Endre ZH
    Clin J Am Soc Nephrol; 2012 Aug; 7(8):1355-64. PubMed ID: 22679181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian bootstrap estimation of ROC curve.
    Gu J; Ghosal S; Roy A
    Stat Med; 2008 Nov; 27(26):5407-20. PubMed ID: 18613217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonparametric estimation and inference for polytomous discrimination index.
    Li J; Feng Q; Fine JP; Pencina MJ; Van Calster B
    Stat Methods Med Res; 2018 Oct; 27(10):3092-3103. PubMed ID: 28178877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.